Cart

[woocommerce_cart]

Related Content

Loading...

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023

PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis (TB) and will be suspending its commercial Johne’s Testing Service.

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023

PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis...

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023

Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need, PBD Biotech is announcing that it has appointed Dr Marie Roskrow to chair its board and has expanded its scientific...

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

January 17, 2023

Identifying those most at risk of active TB disease becomes a priority as fatalities increase. In response to this need,...

Words Matter – how a shared language will accelerate development of TB diagnostics

December 21, 2022

Creating a shared language for talking about tuberculosis has been identified by the Stop TB Partnership as being a constructive step towards achieving the United Nations political declaration to eliminate TB by 2030.

Words Matter – how a shared language will accelerate development of TB diagnostics

December 21, 2022

Creating a shared language for talking about tuberculosis has been identified by the Stop TB Partnership as being a constructive...

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022

Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been revealed by the TAG pipeline report

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

November 22, 2022

Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been...

1 2 … 28 Next »

Phage Based Diagnostics

Cart

Related Content

Targeting global unmet need for rapid molecular diagnostic for human TB

Targeting global unmet need for rapid molecular diagnostic for human TB

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

TB blood-test developers PBD Biotech appoint Dr Marie Roskrow as Chair

Words Matter – how a shared language will accelerate development of TB diagnostics

Words Matter – how a shared language will accelerate development of TB diagnostics

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

Detecting subclinical TB – Actiphage only blood test for mycobacteria highlighted in TAG pipeline report

developers of phage-based diagnostics